Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
Blood (2015)
  • Jennifer R. Brown, Harvard University
  • Susan O'Brien, University of Texas MD Anderson Cancer Center
  • C. Daniel Kingsley, Cancer Institute
  • Herbert Eradat, University of California, Los Angeles
  • John M. Pagel, University of Washington
  • James Lymp, Genentech
  • Jamie Hirata, Genentech
  • Thomas J. Kipps, University of California, San Diego
Link
Disciplines
Publication Date
April 30, 2015
DOI
10.1182/blood-2014-12-613570
Citation Information
Jennifer R. Brown, Susan O'Brien, C. Daniel Kingsley, Herbert Eradat, et al.. "Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial" Blood Vol. 125 Iss. 18 (2015) p. 2779 - 2785
Available at: http://works.bepress.com/john-pagel/64/